Register entry

OPKO Pharmaceuticals, LLC

Data as of · How to read this entry

Registered sites
0
Active NDC listings
8
Labeller names
2
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

8

8 active NDC listings: 8 human prescription drug. By marketing category: ANDA 6, NDA 2.

Dosage formNDCs
capsule6
capsule, extended release2
RouteNDCs
oral8
Labeller name on the listingNDCs
opko pharmaceuticals, llc6
opko pharmaceuticals llc2
Catalogue

Marketed products

8
BrandGeneric nameForm / routeNDC
CyclophosphamideCYCLOPHOSPHAMIDEcapsule, oral70301-2013ANDA
CyclophosphamideCYCLOPHOSPHAMIDEcapsule, oral70301-2015ANDA
Rayaldeecalcifediolcapsule, extended release, oral70301-1001NDA
Rayaldeecalcifediolcapsule, extended release, oral70301-1002NDA
TemozolomideTEMOZOLOMIDEcapsule, oral70301-2005ANDA
TemozolomideTEMOZOLOMIDEcapsule, oral70301-2007ANDA
TemozolomideTEMOZOLOMIDEcapsule, oral70301-2009ANDA
TemozolomideTEMOZOLOMIDEcapsule, oral70301-2011ANDA
Compare

Other companies listing temozolomide

Enquiry

Common questions

Is OPKO Pharmaceuticals, LLC FDA approved?
OPKO Pharmaceuticals, LLC holds no registered establishment of its own; 8 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does OPKO Pharmaceuticals, LLC make?
8 products are listed under OPKO Pharmaceuticals, LLC in the openFDA NDC Directory, most often as capsule; capsule, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.